Matthias A. Karajannis, M.D., is a specialist in the NYU Langone Medical Centers Neurofibromatosis Clinic. The primary area doctor Karajannis specializes in for NF2 care is Oncology.
Individuals involved in drug trials for NF2 at NYU, do so under the care of Doctor Matthias A. Karajannis.
Pediatric Hematology / Oncology - Currently N/A
Principal investigator in developing clinical drug trials.